How do 30,000 genes in our DNA work together to form a large part of who we are? How do one hundred billion neurons operate in our brain? The huge number of factors involved makes such complex networks hard to crack. Now, a study published in the October 25 issue of Science uncovers a strategy for finding the organizing principles of virtually any network ? from neural networks to ecological food webs or the Internet.
U.S. government scientists have demonstrated that a miniature positron emission tomography (PET) scanner, known as microPET, and the chemical markers used in traditional PET scanning are sensitive enough to pick up subtle differences in neurochemistry between known genetic variants of mice. This “proof-of-principle” experiment “opens up a whole new, non-invasive way to study and follow transgenic or genetically engineered strains of mice that serve as animal models for human neurological diseases, such as Parkinson’s and Alzheimer’s disease or psychiatric diseases such as substance abuse, depression, and anxiety disorders,” said Panayotis (Peter) Thanos, lead author of the study.
For estrogen to enhance learning and memory, nerve cells in the brain called cholinergic neurons are essential to the process, suggest animal studies performed by researchers from the University of Pittsburgh School of Pharmacy. “Estrogen replacement in postmenopausal women has important effects on mood and cognition. This research was focused on trying to understand what estrogen does in the brain to reduce the effects on brain aging and cognitive decline,” said Robert Gibbs, associate professor of pharmaceutical sciences at the University of Pittsburgh School of Pharmacy.
New research has provided the first neuro-imaging evidence that the brain’s frontal lobes play a critical role in planning and choosing actions. The research team has found that a small region in the frontal lobe of the human brain is selectively activated when an individual intends to make a particular action and not another. These findings help explain why individuals with frontal lobe damage sometimes act impulsively and often have problems making decisions.
A compound that enables squirrels to hibernate may one day help minimize brain damage that results from stroke. In an animal model for stroke, delta opioid peptide reduced by as much as 75 percent the damage to the brain’s striatum, the deeper region of the brain and a major target for strokes, according to researchers. In fact, evidence suggests that the compound, which puts cells in a temporary state of suspended animation, may help protect brain cells from the ravages of Parkinson’s disease as well.
Biologists have shown for the first time in the laboratory that they can convert some adult human neural stem cells to brain cells that can produce dopamine, the brain chemical missing in Parkinson’s disease. If the researchers can better understand the process and harness this ability, the work may someday lead to new strategies in treating neurodegenerative diseases such as Parkinson’s.
Researchers have found evidence in animals that the young, adolescent brain may be more sensitive to addictive drugs such as cocaine and amphetamines than either the adult or newborn. The work may help someday lead to a better understanding of how the adolescent human brain adapts to such drugs, and provide clues into changes in the brain that occur during drug addiction.
Fatty acids from fish oils and fatty fish can destroy the power station – the mitochondria- in certain types of cancer cells, making the cells commit suicide. These are the conclusions in a Norwegian researcher, who says polyunsaturated omega-3 fatty acid ingested by different leukemia/lymphoma cell lines can cause the cells to shut down.
Researchers have discovered a way to refine an experimental Alzheimer’s vaccine, a finding that could pave the way for new treatment and prevention of the debilitating disease that affects people’s ability to think and recall information. Alzheimer’s occurs when toxic biochemical compounds known as amyloid-beta peptides accumulate in the brain, forming plaque deposits and injuring nerve cells, which eventually causes dementia. In 2000, researchers at the Centre for Research in Neurodegenerative Diseases published a paper showing how the amyloid-beta peptide vaccine blocked the production of the plaques and reversed learning impairment. The vaccine stimulates the body’s immune system into forming antibodies against the plaques in the brain, but it also caused inflamation. This new research claims to have found a way to better isolate the active epitope detected by antibodies. After testing a more refined, targeted amyloid-beta vaccine on mice, the scientists found that the antibodies generated by the vaccine cleared away the plaques — improving cognitive function in the mice and leaving no evidence of brain inflammation.
When you look at a picture, your brain has to put together lines, patterns and shapes to make a meaningful scene. New research by neuroscientists at the University of California, Davis and the University of Minnesota shows that higher regions of the brain can quickly recognize patterns and shapes and tell lower areas of the brain to stop processing the information. The finding confirms predictions from computer models and helps explain how the human brain makes sense of what the eyes see.
Researchers in Pittsburgh have made significant progress in identifying the first susceptibility gene for clinical depression, the second leading cause of disability worldwide, providing an important step toward changing the way doctors diagnose and treat major depression that affects nearly 10 percent of the population. Research results show significant evidence for linkage of unipolar mood disorders to a specific region of chromosome 2q33-35 in women.
Brain images from hundreds of people with schizophrenia at 10 research sites nationwide will be shared in a first-of-its-kind research project funded by the National Center for Research Resources (NCRR), a branch of the National Institutes of Health. The project will create an extensive database of brain information that it is hoped will expand understanding of disabling brain illnesses such as schizophrenia and speed the development of new treatments.